feed,title,long_url,short_url
SeekingAlpha,LifeMD +3.82% on pricing preferred stock offering,https://seekingalpha.com/news/3746484,
SeekingAlpha,Bausch Health reports topline results from second Phase 3 trial of NOV03 in dry eye disease,https://seekingalpha.com/news/3746483,
